clinical trials Archives - Trending Space

Moderna seeks FDA authorization for 4th dose of Covid vaccine shot

Moderna seeks FDA authorization for 4th dose of Covid vaccine shot

March 18, 2022 trendingspace 0 Comments Booster dose, clinical trials, COVID-19, COVID-19 pandemic by country, COVID-19 vaccination in the United States, COVID-19 Vaccines, medical research, Moderna COVID-19 Vaccine, PfizerBioNTech COVID-19 vaccine, RNA vaccines, vaccination, vaccines

Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its

Centre says mixing COVID-19 vaccines a possibility, foreign studies make a strong case- Technology News, Firstpost

Centre says mixing COVID-19 vaccines a possibility, foreign studies make a strong case- Technology News, Firstpost

May 26, 2021 trendingspace 0 Comments astrazeneca, clinical trials, coronavirus, COVID-19, COVID-19 vaccine, inoculation, moderna, Oxford-AstraZeneca, pfizer, Pfizer/BioNtech, Vaccination drive, vaccine efficacy, vaccine mixing

tech2 News StaffMay 26, 2021 17:37:42 IST Facing a shortage of COVID-19 vaccines and long delays in shipments, countries are

Covid: Moderna CEO advocates 3rd vaccine dose to protect people at risk

Covid: Moderna CEO advocates 3rd vaccine dose to protect people at risk

May 23, 2021 trendingspace 0 Comments Bancel, Biotechnology & Medical Research (NEC), clinical trials, COVID-19 vaccine, COVID-19 Vaccines, Health, Health sciences, Magazine Publishing, medical research, Medicine, moderna, Moderna COVID-19 Vaccine, pharmaceuticals, Stphane Bancel, vaccine

Vaccination with a booster shot among as many people as possible is a good way to protect

Have got full advance for 110 mn doses, clarifies: Serum CEO Poonawalla

Have got full advance for 110 mn doses, clarifies: Serum CEO Poonawalla

May 3, 2021 trendingspace 0 Comments Adar Poonawalla, clinical trials, coronavirus, COVID-19, COVID-19 vaccination in India, COVID-19 vaccine, Serum Institute of India, States and union territories of India, vaccine

Pune-based vaccine maker Serum Institute of India will supply 220 million doses to the Centre, state governments

Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154- Technology News, Firstpost

Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154- Technology News, Firstpost

March 12, 2021 trendingspace 0 Comments 2019 coronavirus, bharat biotech, CDSCO, clinical trials, coronavirus, COVID-19, COVID-19 vaccine, India, intranasal vaccine, Nasal vaccine, NITI Ayog, nose, Pandemic, SEC, Serum, trials, vaccine

tech2 News StaffMar 12, 2021 14:49:28 IST After releasing the results from Phase 2 human trials of its COVID-19 vaccine

← Previous